LEF1 Antikörper (AA 75-216)
-
- Target Alle LEF1 Antikörper anzeigen
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
-
Bindungsspezifität
- AA 75-216
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LEF1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Lymphoid enhancer-binding factor 1 protein (75-216AA)
- Isotyp
- IgG
- Top Product
- Discover our top product LEF1 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
- Andere Bezeichnung
- LEF1 (LEF1 Produkte)
- Synonyme
- LEF1 antikoerper, 3000002B05 antikoerper, AI451430 antikoerper, Lef-1 antikoerper, LEF-1 antikoerper, TCF10 antikoerper, TCF1ALPHA antikoerper, TCF7L3 antikoerper, lymphoid enhancer binding factor 1 antikoerper, lymphoid enhancer-binding factor 1 antikoerper, lymphoid enhancer factor XLEF-1B antikoerper, LEF1 antikoerper, lef1 antikoerper, Lef1 antikoerper
- Hintergrund
-
Background: Participates in the Wnt signaling pathway. Activates transcription of target genes in the presence of CTNNB1 and EP300. May play a role in hair cell differentiation and follicle morphogenesis. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1. Regulates T-cell receptor alpha enhancer function. Binds DNA in a sequence-specific manner. PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1 (By similarity). Isoform 3 lacks the CTNNB1 interaction domain and may be an antagonist for Wnt signaling. Isoform 5 transcriptionally activates the fibronectin promoter, binds to and represses transcription from the E-cadherin promoter in a CTNNB1-independent manner, and is involved in reducing cellular aggregation and increasing cell migration of pancreatic cancer cells. Isoform 1 transcriptionally activates MYC and CCND1 expression and enhances proliferation of pancreatic tumor cells.
Aliases: DKFZp586H0919 antibody, FLJ46390 antibody, LEF 1 antibody, LEF-1 antibody, Lef1 antibody, LEF1_HUMAN antibody, Lymphoid enhancer binding factor 1 antibody, Lymphoid enhancer-binding factor 1 antibody, T cell specific transcription factor 1 alpha antibody, T cell-specific transcription factor 1-alpha antibody, TCF 1 alpha antibody, TCF1 alpha antibody, TCF1-alpha antibody, TCF10 antibody, TCF1alpha antibody, TCF7L3 antibody, Transcription factor T cell specific 1 alpha antibody
- UniProt
- Q9UJU2
- Pathways
- WNT Signalweg, Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Hormone Metabolic Process, Nuclear Hormone Receptor Binding, Chromatin Binding
-